Health Data Research UK appoints Professor Trudie Lang as Global Research Director
by The Editorial TeamWebinar: Disease outbreak preparedness and response: education experiences and ideas
by UK Public Health Rapid Support TeamThe Global Health Network welcomes the highly encouraging news on Pfizer/ Biontech COVID-19 vaccine
by EditorialDNDi short film about new treatment for sleeping sickness awarded Grand Prix at inaugural WHO film festival
by The Editorial TeamVideo Competition: Win a Fully Funded Training Workshop at Your Centre for You and Your Colleagues
by The Editorial TeamFree Webinar: Science, technology and innovation for upskilling knowledge-based economies in Africa
by The Editorial TeamParticipant-level data and the new frontier in trial transparency
by Deborah A. ZarinWe have to learn as much as we can about the benefits, risks, costs, and appropriate role of disclosing participant-level data, in service to the ultimate goal of honoring each trial volunteer's altruism.
Access to regulatory data from the European Medicines Agency: the times they are a-changing
by Beate Wieseler, Natalie McGauran, Michaela F Kerekes, Thomas Kaisera milestone for data transparency in clinical research is within reach- it is hoped this is not unnecessarily delayed.
Data sharing: reaching consensus.
by Jimmy WhitworthJimmy Whitworth calls for a more sustainable and palatable pathway be will to build consensus and to create a broad coalition.
Mark Walport and Paul Brest argues that we need to ensure that research outputs are used to maximise knowledge and potential health benefits
Whose data set is it anyway? Sharing raw data from randomized trials
by Andrew VickersIn this paper, Andrew Vickers argues that attitudes towards data sharing in the clinical trial community need to rethought, drastically
A systematic review of barriers to data sharing in public health
by Willem G van Panhuis, Proma Paul, Claudia Emerson, John Grefenstette, Richard Wilder, Abraham J Herbst, David Heymann, Donald S BurkeThis study looks at the challneges of data sharing globally.
Publishing the results of all clinical trials, whoever funds them, is required for ethical, scientific, economic, and societal reasons
Prepublication data sharing
by Toronto International Data Release Workshop AuthorsRapid release of prepublication data has served the field of genomics well. Attendees at a workshop in Toronto recommend extending the practice to other biological data sets.
Sharing health data: developing country perspectives
by Viroj Tangcharoensathien, Jirawan Boonperm, Pongpisut JongudomsukSharing data is not only about the technical dimension such as data management, repositories and libraries; developing countries are concerned about factors that impede data sharing, in particular, fairness
Lack of proportionality. Seven specifications of public interest that override post-approval commercial interests on limited access to clinical data
by Strech D, Littmann JComparing potential commercial interests with seven specifications of relevant public interest reveals the lack of proportionality inherent in the current practices of EMA and NICE.
The double-edged sword of open access to research data
by John A. SpertusJohn A. Spertus suggests that there needs to be some consideration about the practicalities of data sharing- in how it is shared, investment, and ensuring that data are appropriately analyzed
The delay in sharing research data is costing lives
by Josh SommerThis article argues that scientists need to feel greater urgency to share their findings quickly, and they need additional avenues to facilitate this process.